CAPLYTA. am I and to good launch our everyone. full of and of provide Sharon quarter activities Thanks, morning, first commercialization details additional initial the of pleased
promotional of the patient March, the industry’s lockdowns health to efforts community mental and to delivery care disrupt late As challenging beginning access Sharon started just health COVID-XX pandemic in care in our activities CAPLYTA mentioned, educate as were our and providers. the
these and met identified on. quickly we organization, commercial them a challenges head As
education Our both force of to adapting medical team this and those and have our peer-to-peer extremely prescriptions. conditions our our plan agile we challenging and virtual and these growth execute proud refill by market for week-over-week environment, seen business all was a Despite to team’s of circumstances. sales pivoting I’m creative, to new launch activities under in completely ability sustained
is competitive pleased the this July of which rate of steadily their rate especially refill prescriptions. second with has throughout at refilling benchmarks and are CAPLYTA of grown at stage ahead patients The are and launch. We the quarter CAPLYTA into
able of of theater in-person each non-personal We’re of effective reach of existing and also audience week conferences advertising, remote encouraged We’ve our base medical more and our peer-to-peer live virtual and been our medical presentations both riders. personal by our through new journal sales growing mix product and numbers including promotion, CAPLYTA to recently prescribers the marketing to significant interactions addition an team, digital efforts. by prescribing education,
of presentation of our local the into phased audience conducting we and in-person sales consistent For June, deployed the with XXX% began approach sampling by in And virtual the remote we combination our product force deploy continuing sales our second a operating a live conditions. sales a force capability. entire interactions supplemented engagements. majority In in environment, end had virtual to field with by our quarter of engaging force prescribing was mid-June, the
and the as accepting offices with representatives. country activity open parts up appointments call sales significantly person has sales Our begin increased of physician more in
We of expect throughout to the year. this remainder continue the trend
providers, attendance to highly, education they has demonstrated high combined quarter for stronger-than-anticipated research market among resulted prescribe we to peer-to-peer of rate its programs an in are continue on And amongst and continue medical been targeted Additionally the have build increasing attendees intent performance extensive In second weeks CAPLYTA, alone, our months. our safety at We care very all community. who CAPLYTA high, are well prescribers. exceptionally efficacy, that favorable and awareness amongst These dosing. and received citing those programs. found contribute extremely prescribing acceleration the CAPLYTA, free already which virtual, the interest medical awareness have its our prescription titration that providers promotional XXXX education our will in signs once-daily activities in and volume convenient over see to an in we CAPLYTA CAPLYTA fielded study driving by coming the optimism recently and profile, and had CAPLYTA tolerability positive and been our to in-depth to health levels medical
two timing We also determinations D of lives of continue now to it greater both Part as covered CAPLYTA largest we and coverage market of for access coverage Medicare has playing in than achieved quality State channels where channels. formulary is thought our Medicaid broad coverage payer exactly all would. out make and the strong progress XX% in
are up as pleased of California, CAPLYTA population advances states been in activated has particularly the ability to processed Florida. be including New Texas We nation, the and where York, opened has with made state which Medicaid to across our such in the recently channel, high prescriptions fully
final We payer end. coverage in to commercial with year's by the be determination improvements continue coverage see established to channel
fully access operational program supporting Additionally, and patients. affordability our LYTAlink is eligible patient and
of optimizing is Progress educate CAPLYTA, Let additional consumer announced call. the and a open about their and caregivers campaign to about details the new patients Real care campaign, exciting some earlier and The Sharon that this about aim dialogue me now in options. provide treatment to
People care has campaign social issues face. mental amplified depicts a and are real are campaign and that been digital progress and hope particularly of challenging television these of video schizophrenia The on Instagram. platforms, times, ads social current with may CAPLYTA often mental they with health and national care which marketing that schizophrenia to health challenges they which Patients need. the a important. not at includes adults of has Facebook extends risk The the on During environment with care chronic never the media vulnerability. vulnerable homepages health see more with COVID-XX ad, some features receiving
care to patient provider. to order in have connect to encourage with the Additionally, leading about access health care telepsychiatry be dialogue will a virtual CAPLYTA website with platform. partnered platform further From able we patients schizophrenia independent physician a an mental
educating in by progress While prescribing the that we're substantial and very our still expectations. early are the patient are launch we CAPLYTA, physician with delighted our in of audience positive in and …feedback is about making benefits line experience
week-over-week in a further of access increasing We comprehensive program, our exciting are campaign by performance. we're result strong confident our and that CAPLYTA in the prescriptions, medical and encouraged will market DTC prescriber education new growth access, acceleration prescription position
We clinical report Thank on our for CAPLYTA schizophrenia. development care continue treating to call believe Andy Andy? would hand to with a will I to to We discuss leading look commercial patients over progress. our health And choice to become adult you. forward now to programs. like the providers continuing